Delivery Order SPE2DR25D1205-SPE2DR26F0WP3
- Not listed
- The Defense Logistics Agency awarded a $27,213.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery will be fulfilled at...
- The Defense Logistics Agency awarded a $14,002.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military...
- The Defense Logistics Agency awarded a $9,253.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial indefinite delivery/indefinite quantity (IDIQ) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $33,818.41 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens under a firm fixed-price contract. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-competitive set-aside delivery order. Performance of this contract will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a $4,626.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 30, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a $23,960.38 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a $54,357.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $9,749.84 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside delivery order represents a single line item procurement from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WP3Delivery Order
The Defense Logistics Agency awarded a $29,356.38 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 13, 2025. This non-competitive delivery order represents a firm fixed price contract executed on November 12, 2025, and is performed from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor and critical federal medical supply vendor, fulfills this order under its broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) valued at $999,999,999.00 through December 2026. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical supplier for military and federal healthcare systems. Enbrel, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, is procured through DLA's Medical Supply Chain to support the healthcare needs of active-duty personnel, military beneficiaries, and Veterans Health Administration patients. The IDC vehicle under which this order was placed enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally, supporting defense health operations and various federal healthcare programs including those serving the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 11/12/25 |